Susceptibility of zygomycetes to amphotericin B, miconazole, and ketoconazole
Open Access
- 1 November 1981
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 20 (5), 688-690
- https://doi.org/10.1128/aac.20.5.688
Abstract
Susceptibility to amphotericin B, miconazole, and ketoconazole was determined for 25 clinical isolates of zygomycetes in yeast nitrogen base broth and human serum. In yeast nitrogen base broth, 7 of 25 isolates were susceptible to an imidazole or amphotericin B. In serum, all were resistant to the imidazoles and inhibited by amphotericin B, the current drug of choice for infections caused by zygomycetes.This publication has 6 references indexed in Scilit:
- Susceptibility of zygomycetes to human serumMedical Mycology, 1981
- Mechanism of Action of Antifungal Drugs, with Special Reference to the Imidazole DerivativesClinical Infectious Diseases, 1980
- An Evaluation of Two Years of Clinical Experience with KetoconazoleClinical Infectious Diseases, 1980
- The Activity of Ketoconazole in Mixed Cultures of Fungi and Human Fibroblasts: Die Wirkung von Ketoconazol in Mischkulturen von Pilzen und menschlichen FibroblastenMycoses, 1980
- Rhinocerebral Phycomycosis in Association with Diabetic KetoacidosisAnnals of Internal Medicine, 1967
- In vitro activity of amphotericin B on strains of Mucoraceae pathogenic to man.1960